PetVivo Announces 'Transformative' Acquisition of PiezoBioMembrane
PETV sits 38% above its 52-week low of $0.6 on light trading volume (0.4× avg).
Summary
PetVivo Holdings announced a "transformative" acquisition of PiezoBioMembrane, aiming to build a leading functional biomaterials platform. For a company with a market cap under $30 million and a recent history of critically low cash and a going concern warning, this strategic move is highly significant. While financial details are not provided, the acquisition could fundamentally reshape PetVivo's product offerings and future revenue streams. This follows recent equity raises, including $1 million in April and $150,000 in June, which may support such strategic initiatives.
At the time of this announcement, PETV was trading at $0.83 on OTC in the Life Sciences sector, with a market capitalization of approximately $29.1M. The 52-week trading range was $0.60 to $1.69. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.